OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α‐Synuclein in Parkinson's Disease Model
Advanced Science · 2025
DOI: 10.1002/advs.202406700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaomeng Song und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China. Hauptthemen laut MEDLINE: Dopaminergic Neurons, alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Defective clearance and accumulation of α‐synuclein (α‐Syn) is the key pathogenic factor in Parkinson's disease (PD). Recent studies emphasize the importance of E3 ligases in regulating the degradation of α‐Syn. However, the molecular mechanisms by which deubiquitinases regulate α‐Syn degradation are scarcely studied. In this study, it is found that the protein levels of α‐Syn are negatively regulated by ovarian tumor protease deubiquitinase 5 (OTUD5) which protects dopaminergic (DA) neurons in the PD model. Mechanistically, OTUD5 promotes K63‐linked polyubiquitination of α‐Syn independent of its deubiquitinating enzyme activity and mediates its endolysosomal degradation by recruiting the E3 ligase neural precursor cell expressed developmentally downregulated 4 (NEDD4). Furthermore, OTUD5 conditional knockout in DA neurons results in more severe α‐Syn related pathology and dyskinesia after injection of α‐Syn preformed fibrils (PFF). Overall, the data unveil a novel mechanism to regulate the degradation of α‐Syn and provide a new therapeutic strategy to alleviate DA neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
- Key Laboratory of Infection and Immunity of Shandong Province, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
- Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
- Department of Rehabilitation Medicine, The Second Hospital, Shandong University, Jinan, Shandong, 250012, P. R. China.
ORCID-Profile: Huiqing Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Song, X., Liu, T., Yu, L., Ji, Q., Guo, X., Zong, R., Li, Y., Huang, G., Xue, Q., Fu, Q., Liu, B., Zheng, Y., Chen, L., Gao, C., & Liu, H. (2025). OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α‐Synuclein in Parkinson's Disease Model. Advanced Science. https://doi.org/10.1002/advs.202406700
Vancouver
Song X, Liu T, Yu L, Ji Q, Guo X, Zong R, et al. OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α‐Synuclein in Parkinson's Disease Model. Advanced Science. 2025. doi:10.1002/advs.202406700
BibTeX
@article{Song2025,
author = {Song, Xiaomeng and Liu, Tengfei and Yu, Lu and Ji, Qiuran and Guo, Xin and Zong, Runzhe and Li, Yiquan and Huang, Gan and Xue, Qidi and Fu, Qingyi and Liu, Bingyu and Zheng, Yi and Chen, Lin and Gao, Chengjiang and Liu, Huiqing},
title = {OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α‐Synuclein in Parkinson's Disease Model},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202406700}
}
EUVIMED